First IPF Biomarker Clears Initial FDA Step Toward Qualification
PR Newswire —
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- The Prognostic Lung Fibrosis Consortium (PROLIFIC), a collaborative consortium advancing biomarker tools for pulmonary fibrosis (PF) research, announced today that the PROLIFIC Risk Score has been accepted into the U.S. Food and Drug Administration...